Skip to main content
. 2015 Dec 15;10(12):e0144737. doi: 10.1371/journal.pone.0144737

Table 2. Hemodynamic variables.

baseline drug perfusion ischemia reperfusion
30 30 60
Heart Rate (bpm)
con 334 ± 37 316 ± 36 238 ± 43* 249 ± 41*
sil 295 ± 40 305 ± 43 226 ± 117 244 ± 39
kt+sil 313 ± 57 306 ± 54 198 ± 109* 252 ± 56
kt 317 ± 32 298 ± 36 287 ± 48 256 ± 34
RPP (mmHg * bpm)
con 38004 ± 6029 35803 ± 6717 6021 ± 3845* 7840 ± 3220*
sil 34296 ± 4887 35525 ± 4167 4036 ± 2255* 5964 ± 2297*
kt+sil 36083 ± 6829 32697 ± 4745 6403 ± 5231* 6076 ± 2809*
kt 37895 ± 6834 33894 ± 3521 6300 ± 4834* 6736 ± 3338*
LVEDP (mmHg)
con 4 ± 2 5 ± 4 32 ± 13* 72 ± 12* 66 ± 9*
sil 5 ± 2 7 ± 3 30 ± 6* 70 ± 9* 64 ± 8*
kt+sil 4 ± 2 6 ± 3 31 ± 8* 64 ± 12* 60 ± 9*
kt 4 ± 2 6 ± 3 31 ± 9* 77 ± 10* 70 ± 8*
Coronary flow (ml * min -1 /g dry heart weight)
con 101 ± 15 100 ± 14 59 ± 5* 56 ± 3*
sil 95 ± 22 100 ± 21 66 ± 15* 59 ± 13*
kt+sil 100 ± 21 100 ± 21 61 ± 11* 57 ± 14*
kt 92 ± 20 89 ± 23 62 ± 6* 59 ± 7*

Data are mean±SD. con = control; sil = sildenafil; kt = kt5823. RPP = rate pressure product; LVEDP = left ventricular end-diastolic pressure.

*P<0.05 versus baseline.